Author
Queen's UniversityORCID 0000-0001-5985-3698Unclaimed ORCID profile · follow to get notified of new preprints
6 papers
Recent·Most cited
Kartik Sachdeva, Priyanka Yolmo, Abdulhameed Abdulhamed…·Madhuri Koti
The paper examines TLS-adjacent tumor epithelium in bladder cancer, finding enrichment of hypoxia and EMT pathways linked to immune exhaustion and disease progression.
Priyanka Yolmo, Kartik Sachdeva, Alanna Brewer…·Madhuri Koti
The paper identifies atypical B cells (ABCs) as mediators of poor response to BCG immunotherapy in high-risk NMIBC patients, linking their expansion and FCRL5 expression to early recurrence.
Andrew Garven, Jean‐François Paré, Alexandra Robins…·Charles H. Graham
This study identifies immune dysfunction linked to AP-1 in BCG non-responders with NMIBC, suggesting pre-existing immunosenescence contributes to early recurrence.
Mackenzie Brandon‐Coatham, Julia Avian Vassalakis, Hannah Plummer…·Lynne-Marie M Postovit
This study shows that SMARCA4 loss in endometrial cancer leads to cell state chaos, not stemness, causing dedifferentiation through epigenomic dysregulation.
Brian J. Laight, Danielle Harper, Natasha Dmytryk…·Peter A. Greer
Benjamin Ravenscroft, Priyanka Yolmo, Stephen W. Chenard…·Madhuri Koti
This study identifies increased stromal densities of B cells, CD103+ cells, and CD163+ M2-like macrophages as predictors of poor clinical outcomes in BCG-treated NMIBC patients.